Shingles Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Shingles Vaccines Market is Segmented by Product (Shingrix, Zostavax, and SKYZoster), Vaccine Type (Recombinant Vaccine and Live Attenuated Vaccine), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Shingles Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Shingles Vaccine Industry Overview

The shingles vaccines market is moderately competitive and consists of a few market players. With technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new vaccines with fewer side effects. Additionally, the key players are involved in strategic alliances, such as product approvals, acquisitions, and collaborations, with companies that complement their product portfolio. Some of the major market players include GSK plc., Merck & Co., Inc., Curevo Inc, Geneone Life Science, SK bioscience, and others.

Shingles Vaccine Market Leaders

  1. Merck & Co., Inc.

  2. Geneone Life Science

  3. SK bioscience

  4. GSK plc

  5. Curevo Inc

  6. *Disclaimer: Major Players sorted in no particular order
Shingles Vaccine Market Concentration